Paniz-Mondolfi, Alberto, Muñoz, Marina, Florez, Carolina, Gomez, Sergio, Rico, Angelica, Pardo, Lisseth, Barros, Esther C., Hernández, Carolina, Delgado, Lourdes, Jaimes, Jesús E., Pérez, Luis, Teherán, Aníbal A., Alshammary, Hala Alejel, Obla, Ajay, Khan, Zenab, Dutta, Jayeeta, van de Guchte, Adriana, Gonzalez-Reiche, Ana S., Hernandez, Matthew M., and Sordillo, Emilia Mia
Venezuela and Colombia both adopted measures of containment early in response to the COVID-19 pandemic. However, Venezuela's ongoing humanitarian crisis has decimated its health care system, and forced millions of Venezuelans to flee through its porous border with Colombia. The extensive shared border, and illegal cross-border transit through improvised trails between the two countries are major challenges for public health authorities. We report the first SARS-CoV-2 genomes from Venezuela, and present a snapshot of the SARS-CoV-2 epidemiologic landscape in the Colombian-Venezuelan border region. We sequenced and assembled viral genomes from total RNA extracted from nasopharyngeal (NP) clinical specimens using a custom reference-based analysis pipeline. Three assemblies obtained were subjected to typing using the Phylogenetic Assignment of Named Global Outbreak LINeages 'Pangolin' tool. A total of 376 publicly available SARS-CoV-2 genomes from South America were obtained from the GISAID database to perform comparative genomic analyses. Additionally, the Wuhan-1 strain was used as reference. We found that two of the SARS-CoV-2 genomes from Venezuela belonged to the B1 lineage, and the third to the B.1.13 lineage. We observed a point mutation in the Spike protein gene (D614G substitution), previously reported to be associated with increased infectivity, in all three Venezuelan genomes. Additionally, three mutations (R203K/G204R substitution) were present in the nucleocapsid (N) gene of one Venezuelan genome. Genomic sequencing demonstrates similarity between SARS-CoV-2 lineages from Venezuela and viruses collected from patients in bordering areas in Colombia and from Brazil, consistent with cross-border transit despite administrative measures including lockdowns. The presence of mutations associated with increased infectivity in the 3 Venezuelan genomes we report and Colombian SARS-CoV-2 genomes from neighboring borders areas may pose additional challenges for control of SARS-CoV-2 spread in the complex epidemiological landscape in Latin American countries. Public health authorities should carefully follow the progress of the pandemic and its impact on displaced populations within the region. • SARS-CoV-2 genomes obtained from Venezuela reveal the presence of B1 and B.1.13 lineages, suggesting two separate introductions. • All Venezuelan genomes carried a D614G substitution in the spike (S) protein, which has been linked to increased infectivity. • Three substitutions in the nucleocapsid (N) gene were additionally identified in one of the examined genomes. [ABSTRACT FROM AUTHOR]